Dabur India Ltd

Dabur India Ltd Share Price Today: Live Updates & Key Insights

Get insights on Dabur India Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

Dabur India Ltd Share Price Chart

Dabur India Ltd Fundamentals

Traded Volume: 26,59,623

Market Cap(Cr): 91,460

Avg Traded Price 518.14

1 Year return 1.96%

Upper Circuit 525

Lower Circuit 514.3

P/E TTM 51.00

P/B Ratio 10.00

Traded Value(Cr) 13714.35

EPS TTM 10.199

Book value 10.199

Dividend 2.00%

Dabur India Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights Dabur India Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Dabur India Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W -1.25%

1M +2.20%

3M -3.62%

1Y +1.96%

YTD +2.76%

Dabur India Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights Dabur India Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday 29.56L

Day Before Yesterday 24.20L

1W Avg 21.96L

1M Avg 26.50L

3M Avg 29.03L

Dabur India Ltd Technical Details

Dabur India Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 512

Support 2 508

Support 3 501

Pivot Point : 518

Resistance 1 522

Resistance 2 529

Resistance 3 533

Dabur India Ltd Corporate Actions

Dabur India Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Dabur India Ltd’s capital allocation strategies.

All

Ex-Date 07-Nov-2025 Type D Description 2.75/share@275.00% Record Date 07-Nov-2025 Ratio 275.00

Ex-Date 18-Jul-2025 Type D Description 5.25/share@525.00% Record Date 18-Jul-2025 Ratio 525.00

Ex-Date 08-Nov-2024 Type D Description 2.75/share@275.00% Record Date 08-Nov-2024 Ratio 275.00

Ex-Date 19-Jul-2024 Type D Description 2.75/share@275.00% Record Date - Ratio 275.00

Ex-Date 10-Nov-2023 Type D Description 2.75/share@275.00% Record Date 10-Nov-2023 Ratio 275.00

Ex-Date 21-Jul-2023 Type D Description 2.70/share@270.00% Record Date - Ratio 270.00

Ex-Date 03-Nov-2022 Type D Description 2.50/share@250.00% Record Date 04-Nov-2022 Ratio 250.00

Ex-Date 21-Jul-2022 Type D Description 2.70/share@270.00% Record Date - Ratio 270.00

Ex-Date 11-Nov-2021 Type D Description 2.50/share@250.00% Record Date 12-Nov-2021 Ratio 250.00

Ex-Date 29-Jul-2021 Type D Description 3.00/share@300.00% Record Date - Ratio 300.00

Ex-Date 11-Nov-2020 Type D Description 1.75/share@175.00% Record Date 12-Nov-2020 Ratio 175.00

Ex-Date 13-Aug-2020 Type D Description 1.60/share@160.00% Record Date - Ratio 160.00

Ex-Date 13-Nov-2019 Type D Description 1.40/share@140.00% Record Date 14-Nov-2019 Ratio 140.00

Ex-Date 07-Aug-2019 Type D Description 1.50/share@150.00% Record Date - Ratio 150.00

Ex-Date 09-Nov-2018 Type D Description 1.25/share@125.00% Record Date 12-Nov-2018 Ratio 125.00

Ex-Date 04-Jul-2018 Type D Description 1.25/share@125.00% Record Date - Ratio 125.00

Ex-Date 04-Jul-2018 Type D Description 5.00/share@500.00% Record Date - Ratio 500.00

Ex-Date 07-Nov-2017 Type D Description 1.25/share@125.00% Record Date 08-Nov-2017 Ratio 125.00

Ex-Date 05-Jul-2017 Type D Description 1.00/share@100.00% Record Date - Ratio 100.00

Ex-Date 03-Nov-2016 Type D Description 1.25/share@125.00% Record Date 04-Nov-2016 Ratio 125.00

Ex-Date 29-Jun-2016 Type D Description 1.00/share@100.00% Record Date - Ratio 100.00

Ex-Date 05-Nov-2015 Type D Description 1.25/share@125.00% Record Date 06-Nov-2015 Ratio 125.00

Ex-Date 29-Jun-2015 Type D Description 0.75/share@75.00% Record Date - Ratio 75.00

Ex-Date 19-Sep-2014 Type D Description 1.25/share@125.00% Record Date 22-Sep-2014 Ratio 125.00

Ex-Date 27-Jun-2014 Type D Description 1.00/share@100.00% Record Date - Ratio 100.00

Ex-Date 05-Nov-2013 Type D Description 0.75/share@75.00% Record Date 06-Nov-2013 Ratio 75.00

Ex-Date 21-Jun-2013 Type D Description 0.85/share@85.00% Record Date - Ratio 85.00

Ex-Date 31-Oct-2012 Type D Description 0.65/share@65.00% Record Date 01-Nov-2012 Ratio 65.00

Ex-Date 27-Jun-2012 Type D Description 0.75/share@75.00% Record Date - Ratio 75.00

Ex-Date 04-Nov-2011 Type D Description 0.55/share@55.00% Record Date 08-Nov-2011 Ratio 55.00

Ex-Date 29-Jun-2011 Type D Description 0.65/share@65.00% Record Date - Ratio 65.00

Ex-Date 02-Nov-2010 Type D Description 0.50/share@50.00% Record Date 03-Nov-2010 Ratio 50.00

Ex-Date 08-Sep-2010 Type B Description share@1:1 Record Date 10-Sep-2010 Ratio 1:1

Ex-Date 03-Aug-2010 Type D Description 1.25/share@125.00% Record Date - Ratio 125.00

Ex-Date 30-Oct-2009 Type D Description 0.75/share@75.00% Record Date 03-Nov-2009 Ratio 75.00

Ex-Date 29-Jun-2009 Type D Description 1.00/share@100.00% Record Date - Ratio 100.00

Ex-Date 02-Feb-2009 Type D Description 0.75/share@75.00% Record Date 03-Feb-2009 Ratio 75.00

Ex-Date 19-Jun-2008 Type D Description 0.75/share@75.00% Record Date - Ratio 75.00

Ex-Date 29-Oct-2007 Type D Description 0.75/share@75.00% Record Date 30-Oct-2007 Ratio 75.00

Ex-Date 16-Mar-2007 Type D Description 0.75/share@75.00% Record Date 20-Mar-2007 Ratio 75.00

Ex-Date 25-Jan-2007 Type B Description share@1:2 Record Date 29-Jan-2007 Ratio 1:2

Dividends

Announcement Date 07-Nov-2025 Ex Dividend Date 07-Nov-2025 Dividend(%) 275

Announcement Date 18-Jul-2025 Ex Dividend Date 18-Jul-2025 Dividend(%) 525

Announcement Date 08-Nov-2024 Ex Dividend Date 08-Nov-2024 Dividend(%) 275

Announcement Date 19-Jul-2024 Ex Dividend Date 19-Jul-2024 Dividend(%) 275

Announcement Date 10-Nov-2023 Ex Dividend Date 10-Nov-2023 Dividend(%) 275

Announcement Date 21-Jul-2023 Ex Dividend Date 21-Jul-2023 Dividend(%) 270

Announcement Date 03-Nov-2022 Ex Dividend Date 03-Nov-2022 Dividend(%) 250

Announcement Date 21-Jul-2022 Ex Dividend Date 21-Jul-2022 Dividend(%) 270

Announcement Date 11-Nov-2021 Ex Dividend Date 11-Nov-2021 Dividend(%) 250

Announcement Date 29-Jul-2021 Ex Dividend Date 29-Jul-2021 Dividend(%) 300

Announcement Date 11-Nov-2020 Ex Dividend Date 11-Nov-2020 Dividend(%) 175

Announcement Date 13-Aug-2020 Ex Dividend Date 13-Aug-2020 Dividend(%) 160

Announcement Date 13-Nov-2019 Ex Dividend Date 13-Nov-2019 Dividend(%) 140

Announcement Date 07-Aug-2019 Ex Dividend Date 07-Aug-2019 Dividend(%) 150

Announcement Date 09-Nov-2018 Ex Dividend Date 09-Nov-2018 Dividend(%) 125

Announcement Date 04-Jul-2018 Ex Dividend Date 04-Jul-2018 Dividend(%) 500

Announcement Date 04-Jul-2018 Ex Dividend Date 04-Jul-2018 Dividend(%) 125

Announcement Date 07-Nov-2017 Ex Dividend Date 07-Nov-2017 Dividend(%) 125

Announcement Date 05-Jul-2017 Ex Dividend Date 05-Jul-2017 Dividend(%) 100

Announcement Date 03-Nov-2016 Ex Dividend Date 03-Nov-2016 Dividend(%) 125

Announcement Date 29-Jun-2016 Ex Dividend Date 29-Jun-2016 Dividend(%) 100

Announcement Date 05-Nov-2015 Ex Dividend Date 05-Nov-2015 Dividend(%) 125

Announcement Date 29-Jun-2015 Ex Dividend Date 29-Jun-2015 Dividend(%) 75

Announcement Date 19-Sep-2014 Ex Dividend Date 19-Sep-2014 Dividend(%) 125

Announcement Date 27-Jun-2014 Ex Dividend Date 27-Jun-2014 Dividend(%) 100

Announcement Date 05-Nov-2013 Ex Dividend Date 05-Nov-2013 Dividend(%) 75

Announcement Date 21-Jun-2013 Ex Dividend Date 21-Jun-2013 Dividend(%) 85

Announcement Date 31-Oct-2012 Ex Dividend Date 31-Oct-2012 Dividend(%) 65

Announcement Date 27-Jun-2012 Ex Dividend Date 27-Jun-2012 Dividend(%) 75

Announcement Date 04-Nov-2011 Ex Dividend Date 04-Nov-2011 Dividend(%) 55

Announcement Date 29-Jun-2011 Ex Dividend Date 29-Jun-2011 Dividend(%) 65

Announcement Date 02-Nov-2010 Ex Dividend Date 02-Nov-2010 Dividend(%) 50

Announcement Date 03-Aug-2010 Ex Dividend Date 03-Aug-2010 Dividend(%) 125

Announcement Date 30-Oct-2009 Ex Dividend Date 30-Oct-2009 Dividend(%) 75

Announcement Date 29-Jun-2009 Ex Dividend Date 29-Jun-2009 Dividend(%) 100

Announcement Date 02-Feb-2009 Ex Dividend Date 02-Feb-2009 Dividend(%) 75

Announcement Date 19-Jun-2008 Ex Dividend Date 19-Jun-2008 Dividend(%) 75

Announcement Date 29-Oct-2007 Ex Dividend Date 29-Oct-2007 Dividend(%) 75

Announcement Date 16-Mar-2007 Ex Dividend Date 16-Mar-2007 Dividend(%) 75

Bonus

Record Date 10-Sep-2010 Ex-Bonus Date 08-Sep-2010 Ratio 1:1

Record Date 29-Jan-2007 Ex-Bonus Date 25-Jan-2007 Ratio 1:2

Splits

No Split has been declared by DABUR

Others

Rights No Rights has been declared by DABUR

Dabur India Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares Dabur India Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Dabur India Ltd's relative performance and valuation against major competitors.

Stock Name Hindustan Unilever Ltd ₹2433.70 (+0.22%) M. Cap (Cr) 5718.20 1 Yr Return (%) +2.14% P/E (TTM) 52.51 PB Ratio 11.57

Stock Name Godrej Consumer Products Ltd ₹1125.20 (-0.19%) M. Cap (Cr) 1151.35 1 Yr Return (%) -4.54% P/E (TTM) 63.19 PB Ratio 9.46

Stock Name Marico Ltd ₹739.90 (+0.51%) M. Cap (Cr) 960.34 1 Yr Return (%) +25.18% P/E (TTM) 57.64 PB Ratio 20.63

Stock Name Dabur India Ltd ₹515.65 (-1.79%) M. Cap (Cr) 914.60 1 Yr Return (%) +1.96% P/E (TTM) 50.56 PB Ratio 8.83

Stock Name Colgate-Palmolive (India) Ltd ₹2180.60 (+0.04%) M. Cap (Cr) 593.09 1 Yr Return (%) -18.95% P/E (TTM) 44.73 PB Ratio 35.63

Stock Name Procter & Gamble Hygiene and Health Care Ltd ₹12850.00 (-1.37%) M. Cap (Cr) 417.12 1 Yr Return (%) -19.06% P/E (TTM) 50.46 PB Ratio 42.27

Stock Name Gillette India Ltd ₹8276.50 (-1.52%) M. Cap (Cr) 269.73 1 Yr Return (%) -9.78% P/E (TTM) 46.99 PB Ratio 24.42

Dabur India Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by Dabur India Ltd, across its operating activities, investing activities, and financing activities.

PARTICULARS Operating Activities Mar 2025 1622.97 Mar 2024 1653.33 Mar 2023 1561.91 Mar 2022 1319.95 Mar 2021 1704.17

PARTICULARS Investing Activities Mar 2025 -99.00 Mar 2024 -737.50 Mar 2023 -618.57 Mar 2022 -682.80 Mar 2021 -1121.40

PARTICULARS Financing Activities Mar 2025 -1510.68 Mar 2024 -921.82 Mar 2023 -939.83 Mar 2022 -634.79 Mar 2021 -555.04

PARTICULARS Net Cash Flow Mar 2025 13.39 Mar 2024 -4.58 Mar 2023 4.88 Mar 2022 3.46 Mar 2021 28.76

Dabur India Ltd Shareholding Pattern

This shows the ownership breakdown of Dabur India Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter 66.22%

Public 5.48%

Other Institutions 9.35%

FII 10.88%

Mutual Funds 8.04%

About Dabur India Ltd

Dabur India Limited is one of the leading FMCG Companies in India and a global leader in Ayurveda with a portfolio of over 250 Herbal and Ayurvedic products. The Company operate in key consumer products categories like Hair Care, Oral Care, Health Care, Skin Care, Home Care and Foods. Their FMCG portfolio includes five flagship brands with distinct brand identities, 'Dabur' as the master brand for natural healthcare products, Vatika for premium personal care, Hajmola for digestives, Real for fruit juices and beverages and Fem for fairness bleaches and skin care products. The Company operates through three Strategic Business Units, Consumer Care Division (CCD), International Business Division (IBD) and Consumer Health Division (CHD). Their CCD business is divided into four key portfolios: healthcare, personal care, home care and foods. Their CHD business offers a range of healthcare products. Their IBD business includes brands, such as Dabur Amla and Vatika.The Company has a strong manufacturing footprint with own plants at 14 locations in India, which includes Badshah Masala manufacturing unit in Umbergaon, Gujarat. The Foods business is serviced by manufacturing facilities at Newai (Rajasthan) and Siliguri (West Bengal). Outside India, the company has manufacturing facilities in Dubai, Sharjah, Ras-al- Khaimah, Egypt, Nigeria, Nepal and Bangladesh.The company has a wide distribution network, covering 6 million retail outlets with a high penetration in both urban and rural markets. Their products also have a huge presence in the overseas markets and are available in over 120 countries across the globe. Dabur today has manufacturing presence across 8 countries.Dabur India Limited was incorporated on September 16, 1975 for manufacture of high-grade edible & industrial guargum powder and its sophisticated derivatives. In the year 1978, the company launched Hajmola tablet, an Ayurvedic medicine used as a digestive aid. In the year 1979, they set Dabur Research Foundation. Also, they commenced commercial production at the most modern herbal medicines plant in Sahibabad. In the year 1986, the Company was converted into a Public Limited Company. In the year 1988, they launched the pharmaceutical medicines.In the year 1989, the company converted the Ayurvedic digestive formulation into a children's fun product with the launch of Hajmola Candy. In the year 1992, they launched a new range of coconut oil under the brand name 'Anmol'. Also, they developed Dab 10, an intermediate for anti-cancer drug, 'Taxol'. The Company entered into a Joint Venture Agreement with Guldenhorst BV Netherland to form a Company for manufacture and marketing of all types of bubble gum, chewing gum, toffees, chocolate, cocoa related products and sugar based spreading creams etc. In the year 1994, the company entered into capital market with their public issue. Also, they entered into oncology segment during the year. In the year 1996, the company entered into foods business with the launch of Real Fruit Juice, the first local brand of 100% pure natural fruit juices made to international standards. In 1997, the company set up a new manufacturing unit with a high degree of automation at Baddi (H.P.) to produce company's well-known brands, namely Chyawanprash, Janma Ghunti, Ayurvedic Oils and Asva-Arishtas. In the year 1998, Burman family handed over management of the company to professionals. The company signed a joint venture with Bongrain International SA of France to form a new company under the name of Dabon International Ltd. In the year 1999, the company entered into an agreement with their Spanish partner Agrolimen to offload their 49% stake in the joint venture company General De Confiteria India Ltd in favor of an Agrolimen Group Company.In the year 2000, the company launched Efarelle Comfort, a natural menstrual pain reliever. Also, the company's ayurvedic specialties division launched plain isabgol husk under the brand name Nature Care. In the year 2001, the company entered into the highly specialized area of cancer therapy.In the year 2003, the company demerged their pharmaceuticals business from the FMCG business into a separate company as part of plans to provider greater focus to both the businesses. With this, the company now largely comprises of the FMCG business that include personal care products, healthcare products and Ayurvedic Specialities, while the Pharmaceuticals business would include Allopathic, Oncology formulations and Bulk Drugs. Dabur Oncology Plc, a subsidiary of Dabur India, would also be part of the Pharmaceutical business. Also, they made a tie up with Free Markets Inc for using leading edge technologies to execute online markets for its procurement needs. In the year 2005, the company acquired Balsara's Hygiene and Home products businesses, a leading provider of Oral Care and Household Care products in the Indian market for the consideration of Rs 143-crore all-cash deal. In the year 2006, Besta Cosmetics Ltd was amalgamated with the company with effect from April 1, 2006. Also, the company incorporated a subsidiary company under the name Asian Consumer Care Pakistan Pvt Ltd to sell FMCG products in Pakistan. In the year 2007, Dabur Foods Ltd was amalgamated with the company with effect from April 1, 2007 to extract synergies and unlock operational efficiencies. During the year 2009-10, the company acquired 20% of the equity share capital of Fem Care Pharma Limited (FEM) from the public shareholders, in addition to the controlling stake of 72.15% acquired from their existing promoters thereby increasing the total controlling stake to 92.15%. Also, as per the scheme of amalgamation, Fem Care Pharma Ltd was amalgamated with the company with effect from April 1, 2009. The scheme became effective on June 18, 2010.During the year 2010-11, the company acquired Turkey's leading personal care products maker Hobi Kosmetik Group through Dabur International Ltd, a wholly owned subsidiary of the company for USD 69 million. In January 2011, they acquired 100% equity in Namaste Laboratories LLC of the US, a leading ethnic hair care group based in Chicago with operations in US, Europe and Africa, through Dermoviva Skin Essentials Inc, a wholly owned subsidiary of the Company for USD 100 million. They launched India's first fruit-flavoured Chyawanprash. Dabur Chyawanprash was launched in Orange and Mango flavoured variants.In the year 2011, the company launched their first-ever online shopping portal www.daburuveda.com. With this, the company is the first Indian FMCG company to launch a dedicated online shopping portal for its beauty products range. The portal will be the online gateway for consumers to know, understand, buy and gift the exclusive Dabur Uveda range of skincare products. The company acquired Ajanta Pharma's over-the-counter energizer brand '30-Plus'.In January 31, 2012, the company's step down subsidiary, Zeki Plastik Imalati Sanayi ve Ticaret Anonim Sirketi merged with another step down subsidiary - Hobi Kozmetik Imalat Sanayi Ve Ticaret Anonim Sirketi. Accordingly, Zeki Plastik Imalati Sanayi ve Ticaret Anonim Sirketi ceased to be the company's step down subsidiary company with effect from January 31, 2012.In 2012, Namaste Cosmeticos Ltd, became new step down subsidiary Company in Brazil. The company also expanded its range of fruit juices viz. Real Activ.In 2013, Dabur Enters Yoghurt Drink Market With Brand Real Activ. The company Expands Skin Care Portfolio and launches Oxy Life Gel Bleach. The company Launches New Fruit Juice Range: Real SupaFruits. Dabur Launches Indias First Oral Health Portal. In 2014, Dabur Launches India's First Ayurvedic Medical Journal. The company also enters Packaged Coconut Water market with Real Activ.In 2015 Dabur India Ltd inked an agreement with Starcom MediaVest Group (SMG). The company has introduced an array of professional salon facial products for men and women under the Oxlife brand. The company also introduced the sugar-free version of its popular ayurvedic product Chyawanprash named Ratnaprash SugarFree.On 12 October 2015, Dabur India announced its entry into the Jasmine Hair Oil category with the launch of Vatika Jasmine Non-Sticky Coconut Hair Oil. The product, developed after extensive research, provides nourishment of coconut oil, jasmine extracts and is enriched with Silicon Oils that helps restore moisture balance in hair and give smooth, manageable less frizzy hair.On 24 February 2016, Dabur India announced that it has inked a license agreement with the Government of India to commercially produce two new Ayurvedic drugs viz. Ayush-64 for treatment of Malaria and Ayush-82 for management of Diabetes. Dabur India also signed a Memorandum of Understanding (MoU) with the Central Council of Research in Ayurvedic Sciences (CCRAS), an apex research body under the Ministry of AYUSH, Government of India, for collaboration and co-operation in pharmaceutical R&D for different novel dosage forms and drug development in Ayurveda. Dabur India Ltd said it is preparing to commercially produce the two new Ayurvedic medicines within the next 6 months and these medicines will be available in various formats. The Ayurvedic formulations for both these medicines were developed by CCRAS. On 1 November 2016, Dabur South Africa (Pty) Ltd announced an agreement with South Africa's CTL Group of Companies to acquire its Personal Care, Hair Care & Creams businesses for 18.8 million ZAR (around USD 1.5 million). Under the agreement, Dabur South Africa (Pty) Ltd - the wholly-owned subsidiary of Dabur International Ltd - will acquire the business of development, manufacturing, packaging and sale of Personal Care products (Hair Care and Creams) of CTL Contracting Proprietary Limited, in addition to certain equipment of Carbotec Laboratories Proprietary Limited and immovable property from CTL Management and Personnel Services Proprietary Limited. Dabur International Ltd is an overseas subsidiary of Dabur India.On 7 February 2017, Dabur India's pure-play beauty retail venture NewU announced the launch of Sri Lanka's Ayurvedic beauty brand Spice Island in India. This marks the Indian entry of Spice Island, which will be available exclusively at NewU outlets across the country, and will feature a range of premium Skin Care, Bath & Body Care and Hair Care products.On 14 March 2017, Dabur India announced the launch of first-ever Mobile Honey-Testing Lab in India. This unique on-the-go lab has been designed specially to check raw Honey at source to reduce adulteration in honey and ensure that purity is maintained.On 29 March 2017, Dabur India announced the commissioning of its new manufacturing facility in Tezpur, Assam. The plant, set up with an investment of Rs 250 crore, is the most modern and environment friendly manufacturing facility in the consumer goods industry in India. The manufacturing facility, located in Balipara Industrial area, will manufacture the entire range of Dabur's Ayurvedic Medicines, Health Supplements, Hair Oils, Shampoos, Toothpastes, Skin Care and Home Care products. The new facility has been constructed in a record time of eight months since its ground-breaking in July 2016 and will house the most modern production lines for consumer products in India. The state-of-the-art manufacturing facility is spread over 30 acres of land and is expected to give a quantum leap to the capacity of Dabur India to meet the growing demand for its products.On 26 September 2017, Dabur India announced its alliance with Amazon to take its products global. Dabur's collaboration with Amazon will help it expand and increase its product penetration into the US market. Under this collaboration, Amazon will help Dabur take around 30 products from its popular range such as, Vatika hair oil, Meswak toothpaste, Red toothpaste, Chyawanprash to name a few, to consumers in the US. Along with the existing wide range, Dabur will also offer an exclusive range of products specially created for Amazon's global customers. As part of this association, Amazon through its Global Selling Program will provide an avenue to Dabur to take its vast range of well-known and sough-after ayurvedic and natural products to millions of global customers on Amazon.com in the US and eventually across other Amazon marketplaces.In year 2018-19, Dabur Herbal Toothpaste was relaunched with a refurbished marketing mix and packaging upgrade with enhancedfocus on ingredients. During fiscal 2019-20, the Company launched new products in India, mainly including Ethnic Masala Range of Juices in 2 additional variants, Masala Mixed Fruit and Masala Aam Panna, Real Mixed Berries Juice, Real Aloe Vera Kiwi Juice, Real Fruit ORS, Real Koolerz - INR 10 SKU of mango drink, Babool Ayurvedic Toothpaste, Dabur Glucoplus C - Mango Flavour, Amla Kids Hair Oil and Shampoo, Fem Fruit Cr�me Bleach, a range of 7 Ayurvedic Single Herb Churnas which includes three Immunity-boosters like GiloyChurna, Amla Churna and Ashwagandha Churna. The other products in this range are Hareetaki (Harad) Churna, Neem Churna, Arjun ChhalChurna and Brahmi Churna, Fem Fruit Cr�me Bleach, Nature Care Kabz Over for treatment of constipation, a new variant of Hajmola called the HajmolaChatpati Hing, two new fragrances in Odonil Aerosol, Floral Bliss and Ocean Breeze, Dabur ArshoghaniVati, an Ayurvedic medicine beneficial for treatment of piles, Dabur Tulsi drops, Dabur Immunity Kit, Dabur Amla Juice, Dabur Giloy-Neem-Tulsi Juice, Dabur Hand Sanitize, Dabur &Dazzl Surface Sanitizers and Odonil Air Sanitizer. In Overseas markets, it launched VatikaMenz Hair Tonic, Dabur Amla Keratin Serum, Dabur Herbolene Natural Jelly, Real Juices in UAE, Japan and Bahrain, Vatika Hair Wax, ORS Olive Oil Fix-It Range, Vatika Hair Food and Dabur Honitus Herbal Lozenges in UAE. In terms of distribution, the Company increased its direct reach from 1.1 million to 1.2 million, taking the total reach to 6.7 million outlets. Excel Investments (FZC) (previously FZE), in Sharjah, UAE, had become a step down subsidiary company of Dabur India Limited w.e.f. 20th August, 2019 upon acquisition of management control of this new subsidiary by Dabur International Limited (a wholly owned subsidiary of Dabur India Limited). During the year 2020-21, Company expanded their portfolio with the launch of new brands like Dabur Vedic Suraksha Tea, Dabur Pure Herbs tablets and Dabur Himalayan Apple Cider Vinegar. It launched the Dabur Vedic Suraksha Tea. The growth in this portfolio was led by immunity-building medicines like Giloy Ghanvati tablets, Stresscom (Ashwagandha) capsules and premium Chyawanprash variant Ratnaprash. A host of new products were also launched during the year, like Dabur Nasal Drops, to expand the Dabur Ayurvedic Ethicals portfolio. Apart from these, the Company entered the Siddha medicines market with the launch of Kabasura Kudineer, which possesses strong anti-inflammatory, analgesic, anti-viral, anti-bacterial, anti-fungal, antioxidant, hepato-protective, anti-pyretic, anti-asthmatic and immunomodulatory properties. Herbodynamic India Limited was incorporated on 24 February, 2021 as a wholly owned subsidiary Company of the Company. The Company expanded the Honey portfolio with the launch of Tulsi Honey and Ashwagandha Honey.During the year 2022, the Company focused on their power brands, comprising of Dabur Chyawanprash, Dabur Honey, Dabur Lal Tail, Dabur Honitus, Pudin Hara, Dabur Red Paste, Dabur Amla Hair Oil, Real and Vatika. In terms of distribution network, they increased direct reach from 1.28 million to 1.31 million, taking the total reach to 6.9 million outlets. It also added another exclusive brand `London Notes' for fragrances category and launched body mists. It launched various new products such as Dabur Vatika Shampoo, PET Fruit Juice etc.During the year 2022-23, Herbodynamic India Limited, which was a wholly owned subsidiary of the Company has ceased to be subsidiary of the Company w.e.f. January 11, 2023. Asian Consumer Care Private Limited (Bangladesh), step down subsidiary of the Company had become a step down wholly owned subsidiary of the Company w.e.f. November 24, 2022, upon acquisition of remaining 24% of equity shares held by the Joint Venture partner- M/s Advanced Chemicals Industries Limited. Further, post-acquisition, name of Asian Consumer Care Private Limited was changed to Dabur Bangladesh Private Limited w.e.f. February 16, 2023. The Company had acquired 51% equity shareholding of Badshah Masala Private Limited from its existing shareholders and promoters and consequently upon the acquisition, Badshah has become a subsidiary of the Company w.e.f. January 2, 2023.The Company launched Dabur Cool King Hair Oil during the year 2022-23. New product like Vatika Ayurvedic Shampoo, Dabur Herb'l Toothpaste Range, Hajmola LimCola and ChatCola variants, Badam Amla Hair Oil, and Dabur Baby were also introduced in the market taking the count to 25. Herbal Plus (with ingredients like Ginger, coconut, and baking soda) and Herb'l Kids, got launched during 2023.In 2023-24, Company acquired 51% equity stake in Badshah Masala Pvt Ltd and made it a subsidiary on 2 January, 2023. It launched 14 new products in 2024. These launches also marked Dabur's entry into several emerging and growing categories like mosquito repellent liquid vapourisers, cooling hair oils, gel toothpastes, teas, and shower gels.The Company established new consumer goods manufacturing unit in South India in FY 2025. In terms of distribution, the Company increased its direct reach to 1.5 million retail outlets. The Company's total retail reach increased to 8.4 million outlets with addition of around 5,00,000 outlets during the year 2025. Chemist coverage during FY25 increase by around 9,000 outlets to reach 2.79 lakh chemists. Dabur International FZE, the step-down wholly owned subsidiary company of Dabur India Limited has incorporated on April 17, 2025, a new entity in United Kingdom, namely - `Dabur UK Trading Limited`, which is a wholly owned subsidiary of Dabur International FZE. Consequently, `Dabur UK Trading Limited` has become a step-down wholly owned subsidiary company of Dabur India Limited with effect from April 17, 2025.

Whole Time Director & CEO

Mohit Malhotra

Registered office 8/3, Asaf Ali Road, New Delhi, New Delhi, 110002

FAX :91-11-23253488/23276739

Background

Incorporation Year 1975

Face Value ₹1.00

Market Lot 1

Dabur India Ltd Latest News

VIEW MORE NEWS

FAQs on Dabur India Ltd